Abstract 4227
Background
Tumor-associated macrophages (TAMs) are a major component of innate immunity supporting primary tumor growth and metastasis. Chemotherapy is one of the main treatment strategies for solid tumors, while chemoresistance is the major limitation of the chemotherapy for patients with various types of cancer. A number of evidence indicate that TAMs can accumulate in tumors after chemotherapy and contribute to chemoresistance.
Methods
For the endocytic uptake of EGF we used flow cytometry analysis. Confocal microscopy was used for the analysis of stabilin-1-mediated internalization and endocytic trafficking of EGF in CHO cells and in modeled TAMs differentiated in the presence of conditioned supernatants of breast cancer (MCF-7) and colorectal cancer (Colo206F) cell lines. We performed next-generation sequencing of RNA samples obtained from our modeled TAMs. Validation of sequencing data by real-time PCR was performed for selected genes implicated in the endocytic uptake: DNM3, STX8, DENND1A and EHD1.
Results
For the first time we demonstrated that stabilin-1 ectopically expressed in CHO cells mediates endocytic uptake of EGF, key growth factor stimulating progression of breast and colorectal cancer. In the model of primary human TAMs, we have demonstrated that cisplatin decreases stabilin-1-mediated internalization and endocytic trafficking of EGF, without affecting gene expression of scavenger receptor stabilin-1. Molecular mechanisms of cisplatin effect on TAMs were uncovered using high throughput RNA sequencing. Gene set enrichment analysis identified that cisplatin contributes to defects in endocyting machinery reducing membrane biogenesis and vesicular transport. Significant suppression of DNM3, STX8, DENND1A and EHD1 genes expression by cisplatin was confirmed by RT-PCR.
Conclusions
We suggested that suppression of receptor-mediated clearance of tumor-supportive factors, such as EGF, by chemotherapeutic drugs may potentially lead to the tumor progression and/or relapse as a mechanism of macrophage-mediated chemoresistance. This study was supported by grand RSF №19-15-00151.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
National Research Tomsk State University.
Funding
RSF N19-15-00151.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
6171 - Molecular EGFR/PD-L1 profile of glioblastoma: Hints for therapeutic strategies
Presenter: Wojciech Szopa
Session: Poster Display session 1
Resources:
Abstract
4418 - Role of Intraoperative MRI (iMRI) in neurosurgery, potential imaging tool for maximizing gross total resection (GTR) rate of CNS tumours.
Presenter: Shweta Wadhwa
Session: Poster Display session 1
Resources:
Abstract
4791 - Tumor related impairments of neurocognitive functions in patients with brain metastases
Presenter: Lei Wen
Session: Poster Display session 1
Resources:
Abstract
5372 - Is radiation therapy influencing Alzheimer’s in Brain and Head and Neck Cancers?
Presenter: Anas Saad
Session: Poster Display session 1
Resources:
Abstract
2329 - Mature Treatment Results of 120 Cases of Acoustic Neuroma Treated with Cyberknife at a single institution.
Presenter: Shawn Malone
Session: Poster Display session 1
Resources:
Abstract
3207 - A phase II/III trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma: the STELLAR study
Presenter: Cyrillo Brahm
Session: Poster Display session 1
Resources:
Abstract
3589 - CNS penetration and Preliminary Efficacy of Sacutizumab Govitecan in Breast Brain Metastasis and Glioblastoma: A Surgical Study
Presenter: Andrew Brenner
Session: Poster Display session 1
Resources:
Abstract
1969 - Wedge resection with omission of lymph node dissection as an optional treatment strategy in octogenarians or older with early stage non-small cell lung cancers
Presenter: Takahiro Mimae
Session: Poster Display session 1
Resources:
Abstract
5116 - Characterization of lung tumorspheres reveals cancer stem-like cells potential targets and prognostic markers in non-small cell lung cancer
Presenter: Alejandro Herreros Pomares
Session: Poster Display session 1
Resources:
Abstract
5823 - Pulmonary tumor-draining vein exosomal lincRNA-p21 levels impacts non-small cell lung cancer prognosis
Presenter: Joan Castellano
Session: Poster Display session 1
Resources:
Abstract